Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients

BACKGROUND: Due to the different treatments for low-volume metastatic prostate cancer (PCa) as well as high-volume ones, evaluation of bone metastatic status is clinically significant. In this study, we evaluated the correlation between pre-treatment plasma fibrinogen and the burden of bone metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Gan-Sheng, Li, Gang, Li, Yu, Pu, Jin-Xian, Huang, Yu-Hua, Li, Jin-Hu, Yin, Hu-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940101/
https://www.ncbi.nlm.nih.gov/pubmed/31725446
http://dx.doi.org/10.1097/CM9.0000000000000506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940101/
https://www.ncbi.nlm.nih.gov/pubmed/31725446
http://dx.doi.org/10.1097/CM9.0000000000000506

Ejemplares similares